Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
A TE ADA+ patient was identified if an evaluable patient had either of the following: Baseline status of ADA not present and at least 1 postbaseline status of ADA present with titer 2 or more times the minimum required dilution of the ADA assay, or Baseline and postbaseline status of ADA present, with the postbaseline titer being greater than or equal to 4-fold than the baseline titer
This long half-life depends partly on the slow absorption from subcutaneous tissue
If you are 220 lbs that would be equal to 100g of protein per day
The latest results from the 2023 TEXAIS trial indicated that the use of exenatide (5 g, twice daily injections for 5 days) did not significantly reduce neurological damage within 7 days in patients with acute ischemic stroke (trial registration numbers: ACTRN12617000409370 and NCT03287076)
US$ 24.39
US$ 28.60
US$ 23.74
US$ 29.69
US$ 25.65
US$ 22.56
US$ 26.04
US$ 27.86
US$ 26.57
US$ 26.80
